← Blog · MedLegal AI

How Business Valuation Expert Witnesses Get Excluded Under Daubert — and How to Survive the Cross

Verify it yourself — free, no login

See how AI medical-record review links every fact to the exact Bates page that proves it — click any citation and jump straight to the record.

See the 60-second demo →
By John Mahoney · 2026-06-11 · For business-valuation & appraisal experts

Daubert is not a medicine problem. Under Kumho Tire and the 2023 amendment to Federal Rule of Evidence 702, the trial court's gatekeeping applies to every form of specialized testimony — business valuation included. A 20-year study of 2,842 challenges to non-medical experts found that roughly half of those opinions were excluded or partially excluded, and the single most-cited reason was “unreliable methodology.”

The exclusion rarely happens in a written motion alone. It is built, piece by piece, in the deposition cross-examination — where opposing counsel walks a business valuation expert into conceding scope, methodology, or an assumption that unravels the whole opinion. Here are the three traps, and how a prepared expert answers each one.

The three ways business valuation experts lose ground

Scope: testifying outside your lane

The cross-examiner's question sounds simple:

You valued this closely-held company, but you've never operated a business in this industry, have you?

Why it works: The industry-experience scope attack. Anchor to the valuation method and the standard of value.

A stronger answer: “I apply accepted valuation methodology, which is industry-neutral, to the company's financials, comparable data, and the standard of value the matter requires; I disclosed my basis.”

Methodology: the reliability attack

The cross-examiner's question sounds simple:

Your value relied on management's projections — you didn't independently test them against historical performance, did you?

Why it works: Projection reliance — the classic valuation exclusion. Show your independent testing.

A stronger answer: “I benchmarked the projections against the company's history and industry data and disclosed where they diverged; uncorroborated projections aren't the sole basis.”

Assumptions: the one premise that sinks the opinion

The cross-examiner's question sounds simple:

Your discount rate includes a company-specific risk premium you selected — that's a judgment call, isn't it?

Why it works: The discount-rate assumption. Disclose every component and present ranges.

A stronger answer: “I built the discount rate from sourced components, disclosed each input including the specific-company premium and its support, and presented a range.”

How to prepare for the cross before you're sworn in

Every one of those traps is defeatable — but not by reading your report one more time. The experts who survive the cross have done three things:

Practice the cross for free

See an AI cross-examiner run on a business valuation case, and try the live record search — no signup.

Open the Business Valuation expert tools →

Questions? Contact us at [email protected].

See the AI cite its source — no login
Most legal AI is wrong 17–33% of the time. Watch MedLegal AI pin every finding to the exact record page — click any citation and it jumps to the line that proves it.
Watch the 30-second demo →